12/21/2007

GNI Announces Management Change

12/19/2007

GNI Scientists Discovered New Regulatory Mechanism of Key Inflammatory Disease Signalling Pathway

11/21/2007

GNI Announces IND Approval in China for Novel Liver Disease Drug F351

11/07/2007

China Patent and Trademark Office Grants Patent for F351, GNI's Key Therapeutic Product for Liver Disease

10/25/2007

GNI Receives Patent Approval in China for Important Cancer Targets

10/17/2007

GNI Researchers in China Identify Important New Regulator of Inflammation

10/12/2007

Announcement of Changes in Management Organization

10/01/2007

Announcement of Changes in Representative Directors and Executives

09/03/2007

GNI Successfully Completes IPO

08/23/2007

IPO Prospectus-R4

08/17/2007

IPO Prospectus-R3

08/16/2007

IPO Prospectus-R2

08/14/2007

IPO Prospectus-R1

07/31/2007

IPO Prospectus(251 page)